EU, Sanofi Talks on Covid-19 Vaccine Aim for Supply Next Year

European Union negotiations with Sanofi to secure a coronavirus vaccine aim for 300 million doses in the second half of 2021, according to a person familiar with the situation.

The deliberations are part of a European Commission outreach campaign to several drug companies -- Johnson & Johnson, Moderna Inc., CureVac GmbH and BioNTech SE are others -- seeking agreements on the advance purchase of any successful Covid-19 vaccines, according to the person, asking not to be indentified because the talks are confidential.

A Sanofi representative confirmed the number of doses being discussed. BioNTech declined to comment. CureVac didn’t immediately ...